Fused quinazolinone compounds and pharmaceutical compositions comprising fused quinazolinone compounds are provided. The compounds are capable of inhibiting cell-cell interaction mediated by glycosaminoglycans (GAGs), particularly leukocyte adhesion, migration and filtration, and are useful for treating diseases and disorders related to cell adhesion, particularly for the treatment or prevention of inflammatory and autoimmune diseases and disorders and cancer.
-
Page/Page column 34
(2010/11/25)
More Articles about upstream products of 930073-44-2
Get Best Price for930073-44-23-[(3-phenylmethyloxy-4-methoxy)benzylidene]pyrrolo[2,1-b]quinazoline-1,2,3,9-tetrahydro-9-oxo-N-[3-[1-(4-methoxyphenyl)-piperazinyl-4]propyl]-6-carboxamide